Dr. Davey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Crc 4 1479 Bldg 10
10 Center Drive Msc 1460
Bethesda, MD 20892Phone+1 301-496-8029Fax+1 301-480-5560- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1984 - 1987
- Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
Certifications & Licensure
- MD State Medical License 1984 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies Start of enrollment: 1984 Jan 09
- Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies Start of enrollment: 2003 Dec 01
- Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study Start of enrollment: 2008 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- A Single Case Observation: Is the Ebola Virus Soluble Glycoprotein an Indicator of Viral Recrudescence?Wakako Furuyama, Richard T Davey, Daniel S Chertow, Andrea Marzi> ;The Journal of Infectious Diseases. 2023 Nov 13
- 2 citationsVaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.Julio A Huapaya, Jeanette Higgins, Shreya Kanth, Cumhur Y Demirkale, Salina Gairhe, Etsubdink A Aboye, David Regenold, Seynt Jiro Sahagun, Gloria Pastor, Doris Swaim, ...> ;The Journal of Infectious Diseases. 2023 Jun 28
- 1 citationsCellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vacc...Vanessa Raabe, Lilin Lai, Juliet Morales, Yongxian Xu, Nadine Rouphael, Richard T Davey, Mark J Mulligan> ;Vaccine. 2023 Feb 17
- Join now to see all
Journal Articles
- Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 TranslationRichard T Davey, John H Beigel, British Journal of Clinical Pharmacology
Grant Support
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2009–2011
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2009–2011
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeutiNational Institute Of Allergy And Infectious Diseases2002–2006
- Immunologic/Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2005
- Immunologic &Virologic Approaches To HIV 1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2001
- Immunologic And Virologic Approaches To HIV1 TherapeuticNational Institute Of Allergy And Infectious Diseases2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: